Semaglutide for Treatment of Obesity in Patients with T2DM – APICON 2024, New Delhi

Date: 22 February, 2024 – 25 February, 2024Location: New Delhi, Delhi

Dr. Sudhir Bhandari contributed to the academic programme at APICON 2024, New Delhi with a session focused on Semaglutide for Treatment of Obesity in Patients with T2DM.

Programme: APICON 2024, New Delhi
Academic Focus: Semaglutide for Treatment of Obesity in Patients with T2DM